Natsuko K. Kawanishi
Natsuko K. Kawanishi publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics and Cancer Immunotherapy and Biomarkers.
- World rank
- #1,991,295 of 7,710,434 ranked researchers
- Rank in United States
- #604,913 of 1,627,098
- Works
- 103
- Citations
- 567
- Citations per work
- 5.5
What does Natsuko K. Kawanishi research?
Natsuko K. Kawanishi's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (19%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6260.4%
- Medicine6260.4%
- Everything else2221.0%
- Life Sciences1918.6%
- 1Oncology31% of their works
- 2Pulmonary and Respiratory Medicine13% of their works
- 3Surgery11% of their works
- 4Cancer Research10% of their works
- 5Molecular Biology8% of their works
- 6Pathology and Forensic Medicine5% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Cancer Genomics and Diagnostics
- Cancer Immunotherapy and Biomarkers
- Ferroptosis and cancer prognosis
- Esophageal Cancer Research and Treatment
- Gastric Cancer Management and Outcomes
- Pancreatic and Hepatic Oncology Research
- Cytokine Signaling Pathways and Interactions
Which keywords describe Natsuko K. Kawanishi's research?
The keywords of their largest research topics: Chemotherapy, Tumor Microenvironment, Cetuximab, KRAS Mutations, Endoscopic Resection, Cancer, Neoadjuvant Therapy and Cancer Genomics.
- STAT3
- IL-6
- Gastric Cancer
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Esophageal Carcinoma
- Cancer Genomics
- Cancer
- KRAS Mutations
- Tumor Microenvironment
- Chemotherapy
- Cetuximab
- Endoscopic Resection
- Neoadjuvant Therapy
- Cell Death
- Ferroptosis
- Mutational Signatures
- Preoperative Chemoradiotherapy
- Molecular Characterization
- Pancreatic Cancer
- Surgical Complications
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy243 topics
- Tumor Microenvironment224 topics
- Cetuximab141 topic
- KRAS Mutations141 topic
- Endoscopic Resection132 topics
- Cancer112 topics
- Neoadjuvant Therapy112 topics
- Cancer Genomics71 topic
- Cell Death71 topic
- Esophageal Carcinoma71 topic
- Ferroptosis71 topic
- Immune Checkpoint Blockade71 topic
- Mutational Signatures71 topic
- PD-1 and PD-L171 topic
- Preoperative Chemoradiotherapy71 topic
- Gastric Cancer61 topic
- Molecular Characterization61 topic
- IL-641 topic
- Pancreatic Cancer41 topic
- STAT341 topic
- Surgical Complications41 topic
Where does Natsuko K. Kawanishi work?
Natsuko K. Kawanishi's main affiliation in the publication record is USC Norris Comprehensive Cancer Center, United States.
How many publications and citations does Natsuko K. Kawanishi have?
OpenAlex counts 103 works and 567 citations for Natsuko K. Kawanishi, an h-index of 15, ranking #1,991,295 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Natsuko K. Kawanishi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.